Oncology PracticeAdding ACEI to Chemotherapy Does Not Prevent CardiotoxicityApril 19, 2024Patient & Survivor CareBreast CancerLymphoma & Plasma Cell DisordersPreventive CareMixed TopicsNon-Hodgkin LymphomaACC Conference Coverage
Oncology PracticeWhat’s Driving the Higher Breast Cancer Death Rate in Black Women?April 18, 2024Breast CancerBusiness of MedicineDiversity in MedicinePreventive CareMetastatic Breast CancerPractice ManagementPatient & Survivor CareOncologyWomen's Health
Hematology NewsTiming Is Everything: CAR T for Follicular LymphomaApril 18, 2024Non-Hodgkin LymphomaCellular Therapy
Oncology PracticeMicrobial Signature of KRAS-Mutated Colorectal Cancer IdentifiedApril 18, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor Care
Oncology PracticeCertain Women May Face Higher Risk for Second Breast CancerApril 17, 2024Breast CancerMetastatic Breast CancerPatient & Survivor CareOncologyWomen's Health
Oncology PracticeMost Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary CancerGynecologic CancerGene TherapyHead & Neck/Thyroid CancersImmunotherapyLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMetastatic Breast CancerMelanomaNeuro-oncologyNonmelanoma Skin CancerPatient & Survivor CarePreventive CareSarcoma & GISTRenal Cell CarcinomaPediatricsMixed TopicsBusiness of MedicineALLAggressive LymphomasAMLB Cell LymphomaCellular TherapyCLLCMLHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaNon-Hodgkin LymphomaT Cell LymphomasMultiple Myeloma
Hematology NewsPhysicians Own Less Than Half of US Practices; Federal Agencies Want Outside InputApril 17, 2024Business of MedicinePractice Management
Hormone + Radiation Therapy Better Than Either Treatment in Older Men With Early HR+ BCApril 17, 2024Breast Cancer
Impact of Adjuvant Ovarian Function Suppression on Recurrence Risk in Premenopausal HR+ Breast CancerApril 17, 2024Breast Cancer
Adjuvant Chemotherapy May be Omitted in Older Women Aged 80 Years or Older With HR+/HER2- BCApril 17, 2024Breast Cancer
Antibiotic Exposure During Immunotherapy Increases Disease Burden in HER2− Early BC April 17, 2024Breast Cancer
Breast Cancer Radiation Therapy Raises Risk for Nonkeratinocyte Skin CancerApril 17, 2024Breast Cancer
MRI-Based Strategy Can Limit Neoadjuvant Chemotherapy Duration in HR−/HER2+ BCApril 17, 2024Breast Cancer
Novel Treatment Sequence Speeds Up Breast Reconstruction Procedures in Patients With Breast CancerApril 17, 2024Breast Cancer
High TIL Levels Linked to Improved Prognosis in Early TNBC Even in Absence of ChemotherapyApril 17, 2024Breast Cancer